What is Dose B KER-012 used for?

Dose B KER-012 is indicated for Treatment of hypoparathyroidism.

Who makes Dose B KER-012?

Dose B KER-012 is developed by Keros Therapeutics, Inc..

What are the side effects of Dose B KER-012?

Common side effects include Nausea, Headache, Fatigue.

Last reviewed 2026-04-23 · How we verify

Dose B KER-012

Keros Therapeutics, Inc. · Phase 2 active Biologic

Dose B KER-012 is a bone morphogenetic protein (BMP) agonist.

Dose B KER-012 is a bone morphogenetic protein (BMP) agonist. Used for Treatment of hypoparathyroidism.

At a glance

Generic name	Dose B KER-012
Sponsor	Keros Therapeutics, Inc.
Drug class	BMP agonist
Target	BMP receptors
Modality	Biologic
Therapeutic area	Bone disorders
Phase	Phase 2

Mechanism of action

Dose B KER-012 works by activating BMP receptors, which are involved in bone formation and regulation. This activation can potentially lead to increased bone density and reduced bone resorption.

Approved indications

Treatment of hypoparathyroidism

Common side effects

Nausea
Headache
Fatigue

Key clinical trials

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results